Cargando…
Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma
BACKGROUND: Newly diagnosed WHO grade II-III or any WHO grade recurrent meningioma exhibit an aggressive behavior and thus are considered as high- or intermediate risk tumors. Given the unsatisfactory rates of disease control and survival after primary or adjuvant radiation therapy, optimization of...
Autores principales: | Madani, Indira, Lomax, Antony J, Albertini, Francesca, Trnková, Petra, Weber, Damien C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404662/ https://www.ncbi.nlm.nih.gov/pubmed/25890217 http://dx.doi.org/10.1186/s13014-015-0384-x |
Ejemplares similares
-
Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer
por: Köthe, Andreas, et al.
Publicado: (2021) -
Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview
por: Weber, Damien C, et al.
Publicado: (2006) -
A quantitative FLASH effectiveness model to reveal potentials and pitfalls of high dose rate proton therapy
por: Krieger, Miriam, et al.
Publicado: (2022) -
Dose-Painted Intensity Modulated Radiation Therapy Improves Local Control for Locally Advanced Pancreas Cancer
por: Tunceroglu, Ahmet, et al.
Publicado: (2012) -
Combined proton–photon therapy for non‐small cell lung cancer
por: Amstutz, Florian, et al.
Publicado: (2022)